PLX Operating Expenses
Protalix Biotherapeutics Inc · Operating Expenses
PLX Operating Expenses
Latest reported$7.46Mperiod ending
PLX Quarterly Operating Expenses ($10.00K → $7.46M)
Quarterly operating expenses
High-resolution chart · PNG
PLX operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 7,462,000 | |
| 8,477,000 | |
| 9,161,000 | |
| 7,396,000 | |
| 8,616,000 | |
| 6,078,000 | |
| 7,123,000 | |
| 5,593,000 | |
| 6,445,000 | |
| 6,002,000 | |
| 7,245,000 | |
| 7,339,000 | |
| 8,506,000 | |
| 8,962,000 | |
| 8,715,000 | |
| 10,234,000 | |
| 10,190,000 | |
| 11,921,000 | |
| 11,107,000 | |
| 10,236,000 | |
| 10,860,000 | |
| 10,260,000 | |
| 13,904,000 | |
| 10,504,000 | |
| 11,380,000 | |
| 13,527,000 | |
| 12,609,000 | |
| 12,587,000 | |
| 15,391,000 | |
| 13,928,000 | |
| 13,197,000 | |
| 13,441,000 | |
| 9,399,000 | |
| 8,941,000 | |
| 12,333,000 | |
| 9,225,000 | |
| 11,640,000 | |
| 7,166,000 | |
| 8,849,000 | |
| 7,070,000 | |
| 10,025,000 | |
| 8,020,000 | |
| 6,408,000 | |
| 6,307,000 | |
| 8,563,000 | |
| 8,675,000 | |
| 6,888,000 | |
| 8,117,000 | |
| 6,528,000 | |
| 9,778,000 | |
| 9,718,000 | |
| 7,417,000 | |
| 8,640,000 | |
| 7,426,000 | |
| 9,037,000 | |
| 8,583,000 | |
| 12,359,000 | |
| 8,473,000 | |
| 9,152,000 | |
| 9,444,000 | |
| 14,500,000 | |
| 10,260,000 | |
| 2,926,000 | |
| 4,967,000 | |
| 11,291,000 | |
| 9,261,000 | |
| 11,828,000 | |
| 6,046,000 | |
| 5,873,000 | |
| 5,035,000 | |
| 6,292,000 | |
| 6,718,000 | |
| 4,898,000 | |
| 6,263,000 | |
| 3,310,000 | |
| 6,431,000 | |
| 9,335,000 | |
| 3,781,000 | |
| 9,606,000 | |
| 2,537,000 | |
| 26,112 | |
| 21,111 | |
| 26,101 | |
| 35,885 | |
| 20,445 | |
| 10,863 | |
| 32,107 | |
| 43,882 | |
| 59,908 | |
| 29,684 | |
| 48,855 | |
| 33,018 | |
| 30,961 | |
| 34,551 | |
| 52,532 | |
| 35,760 | |
| 36,875 | |
| 40,623 | |
| 156,244 | |
| 58,673 |